Surprising way that genetic mutation causes Huntington's disease changes understanding of the disorder
Scientists at the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have discovered a ...
Toxic ‘Forever Chemicals’ Are Everywhere—New Study Has Linked Them to Cell Death in Our Nervous System
The study is particularly significant because it could help explain the association between these plastic-derived chemicals ...
Harvard Medical School2d
New Understanding of How Genetic Mutation Causes Huntington’s Disease
Study explains long-standing question of why Huntington’s disease symptoms typically do not appear until midlife even though ...
Hosted on MSN1d
Study Unveils Surprising Cause of Brain Cell Death in Huntington's Disease
Scientists at the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have discovered a ...
devdiscourse2d
Unraveling Huntington's Mystery: A Breakthrough in Genetic Research
Scientists uncover how a genetic mutation linked to Huntington's disease stays harmless for years before expanding and causing cell death. The study discovers that DNA repeats must exceed 150 CAGs to ...
Elucidating the mechanism that prevents cell death caused by uncontrolled nuclear autophagy
Macronucleophagy helps control micronucleophagy to protect yeast cells during stress. Through extensive experiments with ...
Surprise finding sheds light on what causes Huntington’s disease, a devastating fatal brain disorder
New research shows that the mutation is, surprisingly, harmless for decades. But it quietly grows into a larger mutation — ...
The American Journal of Managed Care1d
Adjuvant Cemiplimab Significantly Improves Disease-Free Survival in High-Risk Skin Cancer
Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...
The American Journal of Managed Care1d
FDA Grants 2 Traditional Approvals for Acalabrutinib
The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated ...
Monthly Prescribing Reference1d
Calquence Combo Therapy Approved for Previously Untreated Mantle Cell Lymphoma
The Food and Drug Administration (FDA) has approved Calquence ® (acalabrutinib) in combination with bendamustine and rituximab for the treatment of adults with previously untreated mantle cell ...